Authors: O'Malley, FP Parkes, R Latta, E Tjan, S Zadro, T Mueller, R Arneson, N Blackstein, M Andrulis, I

Citation: Fp. O'Malley et al., Comparison of HER2/neu status assessed by quantitative polymerase chain reaction and immunohistochemistry, AM J CLIN P, 115(4), 2001, pp. 504-511

Authors: Poritz, LS Blackstein, M Berk, T Gallinger, S McLeod, RS Cohen, Z

Citation: Ls. Poritz et al., Extended follow-up of patients treated with cytotoxic chemotherapy for intra-abdominal desmoid tumors, DIS COL REC, 44(9), 2001, pp. 1268-1273

Authors: Goss, PE Strasser, K Marques, R Clemons, M Oza, A Goel, R Blackstein, M Kaizer, L Sterns, EE Nabholtz, JM De Coster, R Crump, M Abdolell, M Qi, S

Citation: Pe. Goss et al., Liarozole fumarate (R85246): In the treatment of ER negative, tamoxifen refractory or chemotherapy resistant postmenopausal metastatic breast cancer, BREAST CANC, 64(2), 2000, pp. 177-188

Authors: Gelmon, K Eisenhauer, E Bryce, C Tolcher, A Mayer, L Tomlinson, E Zee, B Blackstein, M Tomiak, E Yau, J Batist, G Fisher, B Iglesias, J

Citation: K. Gelmon et al., Randomized phase II study of high-dose paclitaxel with or without amifostine in patients with metastatic breast cancer, J CL ONCOL, 17(10), 1999, pp. 3038-3047